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Many insurance payers are starting 
to use quality incentive programs 
that utilize quality measures (QMs) 
instead of a fee for service model. 
The goal of this new model and 
many ACOs is to improve quality of 
care while decreasing cost and 
overutilization. Screenings and other 
preventative medicine are a big part 
of this patient centered care (PCC) 
approach. 
Background: 
Colorectal Cancer (CRC) Screening is 
one of the most common QMs. The 
survival rates for CRC are higher if 
the disease is caught earlier.1 Yet 
current screening rates are not 
ideal. There are several different 
screening techniques for CRC: stool 
tests (FOBT and FIT), flexible 
sigmoidoscopy, and colonoscopy. 
The test are good for one, five, and 
ten years respectively.  
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Research and Analysis:  
Colorectal Cancer Screening is a good choice for a quality measure because physicians 
can improve the population health by increasing screening and finding the disease 
sooner to improve outcomes. There are two successful aspects of CRC screening QM: 
Standardization – The definition of appropriate screening techniques and target 
population is consistent across all of the LVHN payers. 
Evidence Based – The target population and screening techniques, which are utilized 
by this quality measure, are supported by clinical evidence and research.2 
Conclusions: 
As insurers move toward quality 
incentives it is important to make 
sure the QMs accurately reflect the 
health of a population. The QM of 
Colorectal Cancer Screening can 
be improved in several ways: 
Improve Data Exchange – Utilizing 
clinical data for QM would increase 
accuracy and make analysis 
faster. Patient survey data would 
also increase accuracy and 
empower patients in a PCC model. 
Outcome Measure – Tracking an 
outco e measure, not a proc ss 
such as screening, would reflect 
the health of a population more 
accurately. Insurers could track 
deaths from CR cancer or age of 
diagnosis. 
Improve the System – Offer 
different types of screenings, make 
data capturing simple and intuitive, 
and implement new ideas such as 
pre-appointment QM surveys. 
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Further information 
Implementing these changes could 
help improve quality incentive 
programs and population health. 
More research is needed into quality 
measures and insurance programs. 
 
Areas for Improvement: 
Data Extraction – Payers can obtain screening data from claims, clinical, or survey data. 
The method is not standardized and each has its own problems with accuracy.3 
Type of Measure – Screening is a process measure in healthcare, and thus does not 
provide the most accurate reflection of population health. 
Data Capture – There are barriers within electronic medical records for collecting QMs 
especially if claims data extraction is utilized. 
 
